Health Catalyst director files initial Form 3

Health Catalyst, Inc. director Steven H. Nelson filed an initial ownership report on Form 3.

Rhea-AI Filing Summary

Health Catalyst, Inc. director Steven H. Nelson filed an initial ownership report on Form 3. This filing establishes his status as a director and confirms that, as of this report, there are no buy, sell, or other insider transactions disclosed in the data provided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Steven H. Nelson’s Form 3 filing for HCAT indicate?

The Form 3 filing shows that Steven H. Nelson is a director of Health Catalyst, Inc. It serves as an initial statement of beneficial ownership, and in the data provided it does not report any insider purchases, sales, or other equity transactions.

Does the Health Catalyst (HCAT) Form 3 show any insider buying or selling?

No. The transaction summary in this Form 3 for Health Catalyst, Inc. shows zero buy, sell, exercise, gift, tax withholding, or restructuring transactions. It functions purely as an initial ownership report without recording any trading activity in the company’s securities.

What role does the reporting person hold at Health Catalyst (HCAT)?

The reporting person, Steven H. Nelson, is identified as a director of Health Catalyst, Inc. This role typically involves board-level oversight and governance responsibilities, and the Form 3 formally records his status as an insider subject to SEC reporting requirements.

Why is a Form 3 important for Health Catalyst (HCAT) investors?

Form 3 marks when an individual becomes an SEC-reporting insider at Health Catalyst, Inc. It establishes a baseline for future Forms 4 and 5, which will disclose any subsequent trades or equity awards, improving transparency around director and officer holdings in the stock.

Does the Form 3 for HCAT include any derivative securities details?

No derivative positions are shown in the data for this Form 3. The derivative summary is empty, and the transaction summary indicates no derivative exercises or related transactions, so only the insider’s status as a director is clearly established here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 05:16 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nelson Steven H

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY

SUITE 300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/01/2026

3. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No Securities are beneficially owned.

No securities are beneficially owned.

	/s/ Benjamin Landry, as Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)